Cohort Studyhigh evidence

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·June 24, 2026·PMID 42383941

Why it matters

Sarcopenic obesity is a clinically meaningful risk phenotype that can be assessed from routine cardiac imaging, offering a practical tool for risk stratification in patients undergoing CMR. It also highlights potential therapeutic targets like ACVR2B, relevant to emerging combination therapies.

Infographic summary of Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled